Atlas Trials

Anlotinib and Benmelstobart in DTC

Clinical trial NCT07193186 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07193186
Sponsor
Fudan University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Thyroid Cancer
Start date
2026-04-01
Primary completion
2029-12-31
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.